Back to results
CompletedPhase 1

Study to Investigate the Tolerability, Steady-state Pharmacokinetics and Erythrocyte COMT Inhibition of BIA 3-202

NCT02772627

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Human Pharmacology Unit - BIAL - Portela & Ca, S.A.

S. Mamede Do Coronado, S. Mamede Do Coronado, Portugal

View on ClinicalTrials.gov
Study to Investigate the Tolerability, Steady-state Pharmacokinetics and Erythrocyte COMT Inhibition of BIA 3-202 — TrialFind